Walleye Trading LLC Beam Therapeutics Inc. Put Options Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$17.69 - $30.76 $72,529 - $126,116	4,100 Added 17.6%	27,400 $745,000
Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $52,923 - $74,658	-2,300 Reduced 8.98%	23,300 $560,000
Q2 2023 Aug 14, 2023	BUY	$29.32 - $35.99 $243,356 - $298,717	8,300 Added 47.98%	25,600 $817,000
Q1 2023 May 15, 2023	SELL	$30.15 - $48.79 $476,370 - $770,882	-15,800 Reduced 47.73%	17,300 $529,000
Q4 2022 Feb 14, 2023	BUY	$36.73 - $51.6 $40,403 - $56,760	1,100 Added 3.44%	33,100 $1.29 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $923,128 - $1.63 Million	23,200 Added 263.64%	32,000 $1.52 Million
Q2 2022 Aug 08, 2022	BUY	$29.86 - $62.36 $146,314 - $305,564	4,900 Added 125.64%	8,800 $341,000
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $209,547 - $320,424	3,900 New	3,900 $223,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.